← Leaderboards
Oleg V Tsodikov
Cornell University
$1,004,472
Attributed
$2,999,539
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $652.2K · FY2008–24$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,999,539 · 2
By mechanism
R01$2,992,600 · 1
P41$6,939 · 1
Top collaborators
- Markos Leggas5 shared
- Jurgen Tiberius Rohr5 shared
Most similar at Cornell University
Same institution · by research overlap
- Marcus Smolka$8,381,271
- Christopher Akinleye Alabi$3,115,960
- Ankur Singh$11,314,880
- Charles Richard Kissinger$68,307
- Sarah Emily Lower$43,003
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsComplexDna BindingCombined Modality TherapyAntineoplastic AgentsAnimal ModelBindingCancer DiagnosisAffectCollaborationsBiophysicsBone TissueCytotoxicCancer CellCytotoxicityAnalogCell ModelCellsBiochemicalChildBiologicalClinical TreatmentClinical TrialsDesign
Grant awards (6)
Mechanistic and pharmacologic studies of selective mithramycin analogues targeting EWS-FLI1 in Ewing sarcoma$551,064
R01 · FY2024 · CA · contact PI
Mechanistic and pharmacologic studies of selective mithramycin analogues targeting EWS-FLI1 in Ewing sarcoma$579,770
R01 · FY2023 · CA · contact PI
Mechanistic and pharmacologic studies of selective mithramycin analogues targeting EWS-FLI1 in Ewing sarcoma$592,330
R01 · FY2022 · CA · contact PI
Mechanistic and pharmacologic studies of selective mithramycin analogues targeting EWS-FLI1 in Ewing sarcoma$617,234
R01 · FY2021 · CA · contact PI
Mechanistic and pharmacologic studies of selective mithramycin analogues targeting EWS-FLI1 in Ewing sarcoma$652,202
R01 · FY2020 · CA
STRUC STUD OF E COLI 3-DEOXY-D-MANNO-OCTULOSONATE 8-PHOSPHATE PHOSPHATASE, YRBI$6,939
P41 · FY2008 · RR · contact PI